Dow jumps 600 points as oil tumbles, earnings week lifts US stocks

• Brent crude fell 4.9% and WTI dropped 6.3% on easing geopolitical concerns, helping ease inflation worries and boosting market sentiment after a volatile July
• Markets are pricing in a 62.7% probability of a 25-basis-point Fed rate hike in September, with Friday's jobs report expected to show 87,500 jobs added in July
• Healthcare stocks moved on merger speculation between Bristol Myers Squibb and AstraZeneca for a potential $400 billion deal, while tech earnings from SpaceX, Palantir, and AMD are expected this week

Market Summary: Dow Surges on Falling Oil Prices and Earnings Optimism

Market Performance:

US stocks rallied Monday with the Dow Jones jumping 640 points (+1.22%), the S&P 500 gaining 0.59%, and the Nasdaq rising 0.49%. The advance followed easing Middle East tensions after President Trump announced cancellation of planned Iran strikes.

Energy Market Impact:

Oil prices plunged sharply, with Brent crude down 4.9% and West Texas Intermediate falling 6.3%. The decline alleviated inflation concerns that had complicated the Federal Reserve's policy outlook. Treasury yields retreated, with the 10-year dropping 7 basis points to approximately 4.67%.

Key Economic Indicators:

• Fed rate hike probability: 62.7% chance of 25-basis-point increase in September
• Expected July jobs report: 87,500 new positions (up from 57,000 in June)
• Forecast unemployment rate: 4.3% (from 4.2%)

Earnings and Sector Focus:

Technology stocks showed mixed performance as AI spending scrutiny continues. Notable movers included Palantir (+2.04%), while AMD dropped over 2% and Micron fell 4% on Chinese competition concerns. Major tech earnings expected from SpaceX, Palantir, AMD, SanDisk, and Western Digital.

Healthcare M&A Activity:

Bristol Myers Squibb and AstraZeneca held preliminary merger discussions that could create a nearly $400 billion pharmaceutical giant. Bristol Myers shares gained on the speculation.

Other Corporate News:

Marriott International declined 5% on weak Q3 guidance, while Tyson Foods fell 4% after cutting full-year profit outlook.

Market Context:

The rally provides relief after volatile July trading driven by AI investment concerns, rate hike expectations, and geopolitical tensions.